Published: Tuesday, January 27, 2004 at 6:01 a.m.
Last Modified: Tuesday, January 27, 2004 at 12:40 a.m.
8 women, 4 men make up Stewart jury
The jury, selected from a pool of hundreds, was seated Monday to decide whether Stewart lied to investigators about a well-timed stock sale in 2001. Opening statements are set for this morning.
Hostile takeover bid launched for drugmaker
Outlining the offer that would create a new No. 3 drugmaker with annual revenues of 25 billion euros ($31.5 billion), Sanofi - the maker of the sleeping pill Ambien - talked down Aventis' track record in growth and profitability. Aventis - the maker of allergy medicine Allegra - hit back in a statement highlighting legal challenges to key Sanofi patents and warning shareholders not to be taken for a ride.
Report: MCI can sue ex-execs at WorldCom
Audit: Parmalat debt more than reported
Hollinger takes legal steps to stop sale
Hollinger International also adopted a "poison pill" measure, a defensive tactic used in corporate takeover battles that would allow minority shareholders to take a greater stake in the company in an attempt to stop a sale.
- Compiled from The Associated Press
Reader comments posted to this article may be published in our print edition. All rights reserved. This copyrighted material may not be re-published without permission. Links are encouraged.
Comments are currently unavailable on this article